.jpg)
On 16 May 2025, Ador Multiproducts Limited, a publicly listed entity (BSE Scrip Code: 523120), announced a major development approved by its Board of Directors regarding the allotment of equity shares and convertible warrants on a preferential basis, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Equity Share Allotment:
The board has approved the allotment of 48,87,356 equity shares, having a face value of ₹10 each, at a price of ₹31.41 per share, aggregating to ₹15,35,11,852. This allotment has been made to two individuals from the “Non-Promoter” category, who will transition into the Promoter & Promoter Group category post the open offer:
| Sr. No. | Name of Allottee | Category Status | Equity Shares Allotted |
|---|---|---|---|
| 1 | Mr. Arvinder Singh Pasricha | Non-Promoter → Promoter Group | 26,36,705 |
| 2 | Mrs. Aman Pasricha Balsara | Non-Promoter → Promoter Group | 22,50,651 |
As a result of this allotment, the paid-up equity share capital of Ador Multiproducts now stands increased to ₹9,56,09,890, divided into 95,60,989 equity shares of ₹10 each.
Warrant Allotment:
In addition, the company has approved the allotment of 93,12,364 fully convertible warrants, each priced at ₹31.41, amounting to a total of ₹29,25,01,353. These warrants are issued on a preferential basis to five investors under the "Non-Promoter" category, with two of them (Arvinder and Aman Pasricha) also receiving equity shares.
| Sr. No. | Name of Allottee | Category Status | Warrants Allotted |
|---|---|---|---|
| 1 | Mr. Arvinder Singh Pasricha | Non-Promoter → Promoter Group | 27,95,502 |
| 2 | Mrs. Aman Pasricha Balsara | Non-Promoter → Promoter Group | 27,95,502 |
| 3 | Mr. Goonmeet Singh Chauhan | Non-Promoter | 23,46,901 |
| 4 | Mr. Vinay Kumar Singh | Non-Promoter | 11,73,451 |
| 5 | VNAM Advisors LLP | Non-Promoter | 2,01,008 |
Strategic Implication:
The issuance of warrants and shares totalling ₹44.60 crores suggests a significant fundraise for strategic expansion, working capital needs, or investment in new business ventures. The conversion of these warrants will further dilute equity but strengthen the capital base of the company.
The participation of Mr. Arvinder Singh Pasricha and Mrs. Aman Pasricha Balsara, both set to become part of the Promoter Group post open offer, indicates a shift in promoter holding structure and possibly, strategic management changes.
This fundraising move aligns with Ador Multiproducts’ objective of accelerating its operational capacity and potentially expanding its business model.
Regulatory Compliance:
The company has made this announcement to the BSE in compliance with Regulation 30 of SEBI LODR Regulations, ensuring full transparency with stakeholders and shareholders.
Summary of Key Figures:
-
Equity Shares Allotted: 48,87,356 shares
-
Equity Share Allotment Value: ₹15.35 crore
-
Warrants Issued: 93,12,364
-
Warrants Issue Value: ₹29.25 crore
-
New Paid-Up Capital: ₹9.56 crore (95.6 lakh equity shares)
-
Total Fund Raised: ₹44.60 crore (via shares and warrants)
The Current active IPO are Accretion Pharmaceuticals.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst
.png)
.jpeg)
.jpeg)
